SCHEMBL2761768

SCHEMBL2761768

CC(C)Oc1ccc2c(c1)C(=O)OC(C)(C)O2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLK2 Q86UE8 3/20 0.41
▸ ALDH1A1 P00352 6/20 0.39
▸ GAA P10253 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ STAT1 P42224 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31217566 0.83 PPIB (0.54) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL2494139 0.74 MAOB (0.57) ALDH1A1KMT2AMEN1SMN1; SMN2NPC1
SCHEMBL734522 0.74 KDM4E (0.47) ALDH1A1GAAKDM4EMAPTSMN1; SMN2
SCHEMBL2762199 0.73 MEN1 (0.47) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL730039 0.72 KMT2A (0.42) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL6032230 0.72 TSHR (0.40) ALDH1A1GAAKMT2AMAPTSMN1; SMN2
SCHEMBL3524389 0.72 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTLMNA
SCHEMBL29690270 0.72 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTLMNA
SCHEMBL2472619 0.72 MAPT (0.57) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL1811733 0.72 RAB9A (0.49) ALDH1A1GAAKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8324405-B2 Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors FIBROGEN, INC. (US) 2012-12-04 — — US disclosed
US-20100331400-A1 CHROMENE DERIVATIVES AND USE THEREOF AS HIF HYDROXYLASE ACTIVITY INHIBITORS FIBROGEN, INC. 2010-12-30 — — US disclosed
WO-2009100250-A1 CHROMENE DERIVATIVES AND USE THEREOF AS HIF HYDROXYLASE ACTIVITY INHIBITORS FIBROGEN, INC. (US) 2009-08-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331400-A1 CHROMENE DERIVATIVES AND USE THEREOF AS HIF HYDROXYLASE ACTIVITY INHIBITORS HIF1AN, HIF1A, EGLN2 TLK2 4032/4885ALDH1A1 202/4885GAA 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback